Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ranica
Clinical trial register · Italy

Clinical Trials in Ranica, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Ranica

29 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Mario Negri Institute for Pharmacological Research
Not applicable
90
Bergamo, Ranica
2026-09
Not yet open
Thyroid Hormones in CKD
NCT07663773Chronic Kidney Disease (Stages 4 and 5)
Mario Negri Institute for Pharmacological Research
Observational
51
Ranica
2026-09
Not yet open
Omics of Rituximab-resistance
NCT07416942Membranous Nephropathy
Mario Negri Institute for Pharmacological Research
Observational
120
Ranica
2026-04
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals
Phase 2
32
Ranica, Brescia, Pavia
2026-03-26
Not yet open
Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome
NCT07233330Nephrotic Syndrome,Idiopathic
Mario Negri Institute for Pharmacological Research
Phase 2
10
Ranica
2026-02
Not yet open
Mechanisms Underlying SGLT2i Kidney Effect in DKD Progression
NCT07270198Diabetic Kidney Disease (DKD)
Mario Negri Institute for Pharmacological Research
Not applicable
100
Ranica
2026-02
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Milan, Ranica, Torrette
2025-09-19
Active, closed
Mario Negri Institute for Pharmacological Research
Observational
100
Ranica
2025-06-12
Recruiting
New Advanced Vascular Imaging Ultrasound Protocols
NCT06841887Renal Diseases, Cerebral Disorder
Mario Negri Institute for Pharmacological Research
Observational
60
Ranica
2025-05-09
Recruiting
Biogen
Phase 3
454
Bari, Fontevivo, Modena, Piacenza, Trieste, Genoa, Brescia, Ranica
2025-05-08
Active, closed
Mario Negri Institute for Pharmacological Research
Observational
50
Bergamo, Ranica
2025-04-01
Active, closed
Medical Images Collection Research
NCT06354829Kidney Diseases, Brain Diseases
Mario Negri Institute for Pharmacological Research
Observational
300
Ranica
2025-01-07
Active, closed
Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva
Observational
4,300
Ranica
2024-12-24
Recruiting
An Outcome Analysis of Primary Membranous Nephropathy
NCT06242327Membranous Nephropathy
Mario Negri Institute for Pharmacological Research
Observational
500
Bergamo, Ranica
2024-11-29
Active, closed
Mario Negri Institute for Pharmacological Research
Observational
100
Ranica
2024-11-08
Active, closed
Mario Negri Institute for Pharmacological Research
Observational
100
Ranica
2024-10-12
Recruiting
Mario Negri Institute for Pharmacological Research
Observational
100
Ranica
2024-03-19
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Ranica, Milan, Roma
2024-02-28
Recruiting
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
NCT05996731Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney, Healthy
Mario Negri Institute for Pharmacological Research
Not applicable
105
Ranica
2024-02-21
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bari, Ranica, Brescia, Milan, Roma, Torino, Naples
2023-10-02
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Bari, Foggia, Naples, Modena, Trieste, Pavia, Ranica
2023-07-06
Active, closed
New Analytic Tools for aHUS and C3G Diagnosis
NCT05985122Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy
Mario Negri Institute for Pharmacological Research
Not applicable
180
Ranica
2023-07-01
Active, closed
Apellis Pharmaceuticals, Inc.
Phase 3
100
Milan, Ranica, Rome
2023-05-29
Recruiting
Mario Negri Institute for Pharmacological Research
Not applicable
112
Ranica
2023-05-03
Active, closed
Multiparametric MRI in Healthy Volunteers and CKD Patients
NCT05229263Chronic Kidney Diseases, Healthy
Mario Negri Institute for Pharmacological Research
Not applicable
140
Ranica
2022-11-25
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Ranica, Milan, Roma
2021-07-28
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals
Phase 3
225
Bari, Ranica, Roma
2019-10-03
Recruiting
Autoreactive B Cells in Membranous Nephropathy
NCT04095156Membranous Nephropathy
Mario Negri Institute for Pharmacological Research
Observational
86
Ranica
2019-09-25
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Ranica, Milan, Bari, Catania, Catanzaro, Lecco, Modena, Pavia
2018-12-11
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/ranica

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Ranica.

How many clinical trials are recruiting in Ranica?

13 of the 29 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 5 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ranica), 29 studies
PhaseStudiesRecruitingShare
Observational12441.4%
Phase 38527.6%
Not applicable6220.7%
Phase 23210.3%

Most active sponsors

Lead sponsors with the most studies (Ranica)
Lead sponsorStudiesRecruiting
Mario Negri Institute for Pharmacological Research186
Novartis Pharmaceuticals65
Alexion Pharmaceuticals, Inc.11
Apellis Pharmaceuticals, Inc.10
Biogen11
Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva10
Travere Therapeutics, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.